GLP-1 Gummies and Drops: Are Non-Traditional Oral Formats Effective?

Of all the oral GLP-1 formats on the market, gummies and drops are the two that lean hardest into consumer convenience — no swallowing a tablet, no dissolving-in-mouth texture, just a flavored liquid or a chewable candy. That convenience is real. Whether it comes with a real absorption mechanism behind it is a separate, more complicated question.

Sublingual Drops: The Theory

Sublingual drops are held under the tongue rather than swallowed, on the premise that the thin, blood-vessel-rich tissue there can absorb the drug directly into the bloodstream, skipping the stomach's acidic, enzyme-rich environment entirely. This is a legitimate absorption route for certain drugs — sublingual nitroglycerin for chest pain is the textbook example most people have heard of. The catch is that route works best for small, lipid-soluble molecules that can passively cross the mucosal membrane. Semaglutide is a roughly 4,000-dalton peptide — large and water-soluble — which is a poor structural match for that kind of passive absorption.

No permeation-enhancer technology equivalent to SNAC has been validated for sublingual use, and there is currently no published human clinical trial establishing a specific bioavailability figure for sublingual semaglutide or tirzepatide. We covered the underlying mechanism in more depth in our how oral GLP-1s work guide.

Gummies: Convenience First, Not a New Delivery Science

Gummies are chewed and swallowed, which mechanically puts them in the same category as any other swallowed oral formulation — they face the same stomach-acid, enzyme-degradation gauntlet as a capsule or tablet would, unless specifically formulated with an absorption enhancer. Eden Health is currently the provider offering a compounded GLP-1 gummy alongside its drop option. The gummy format doesn't represent a different or improved absorption mechanism compared to the drops — it's primarily a palatability and convenience play, which is a reasonable thing to prioritize, just not a claim about superior drug delivery.

So Do They Work?

Here's the honest, uncomfortable answer: nobody can currently point to a published human clinical trial that measures how much active semaglutide or tirzepatide actually reaches the bloodstream from a sublingual drop or a compounded gummy. That's genuinely different from saying "they don't work" — an absence of trial data isn't proof of failure — but it does mean any claim of equivalence to the SNAC-based tablets or the injectable pen is not something the current evidence supports. Patient reports on these products vary widely, which is exactly what you'd expect from a product category without a validated, consistent absorption mechanism behind it.

Choosing Between Them

• Taste and daily convenience matter most to you: gummies (Eden) tend to be the most palatable option in this format category, based on user reports.
• You want the lowest price in this format: sublingual drops from MadeMed or Direct Meds are generally the cheaper entry point.
• Evidence behind the exact mechanism is your top priority: neither format currently matches the SNAC-enabled tablets or Foundayo's small-molecule approach on that front — worth reading our full oral GLP-1 comparison before deciding.